“Akt–the Mammalian Target of Rapamycin (mTOR) Pathway Inhibition Increases Cervical Cancer Cell Chemosensitivity to Active Form of Irinotecan (SN-38)” (2013) International Journal of Integrated Health Sciences, 1(1), pp. 13–21. Available at: https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/103 (Accessed: 18 July 2026).